Latest filing published 25 Aug 2026 for IPSEN SA, €620k. Read the official filing
Not enough history yet: 0 closed purchases, at least 2 are needed.
Marc de Garidel Thoron is a declared insider at 2 companies (chief executive); the most frequent names are Abivax and Ipsen SA. In total, 19 filings cover trades dated from 11 July 2024 to 24 August 2026.
In open-market terms, that means 1 purchase on one side and 2 sales worth €1.2M on the other. The totals exclude 1 filing filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 12 share grants and 4 option exercises. Since January 2026: 1 purchase and 2 sales on the market.
The newest entry dates from 25 August 2026: an open-market sale of €620k, in Ipsen SA. The last insider purchase was made public on 26 May 2026, 144 days ago. Filings reach the AMF feed a median of 4 days after the trade. The legal deadline for notifying a trade is three business days (MAR article 19). Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by AMF and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
19 of 19 declarations
Ipsen’s chairman sold EUR 620,488 after a strong year for the stock. Here is how that cluster reads against pharma, regu...
Ipsen’s board chair sold EUR 620k after a strong H1 and a 38% year-to-date run. The cluster, peers, and risks matter mor...